Heartfelt Technologies is currently running two major clinical trials to evaluate how passive lower-limb edema monitoring can support earlier intervention and improve outcomes in heart failure.
🇺🇸 HEARTFELT Study
A United States randomized crossover trial evaluating whether the Heartfelt device, used with protocolized alerts, can reduce heart failure hospitalizations and improve monitoring data availability in patients at high risk of decompensation.
🇬🇧 ME-HF Study
A UK-wide NHS study assessing whether daily passive edema monitoring can identify deterioration earlier, support timely treatment decisions, and reduce unplanned hospital visits while fitting into routine care.